Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms. [electronic resource]
- Cancer chemotherapy reports
- 477-80 p. digital
Publication Type: Clinical Trial; Journal Article
0069-0112
Clinical Trials as Topic Drug Evaluation Drug Therapy, Combination Female Humans Lymphoma--drug therapy Neoplasms--drug therapy Sarcoma--drug therapy Time Factors Vinblastine--adverse effects Vincristine--adverse effects